$OMER
OMEROS CORP Stock $omer

$omer Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924017047 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$13.81M	$12.26M	$11.10M
YoY Change	22.63%	10.46%	1.31%
% of Gross Profit
Research & Development	$45.35M	$26.77M	$24.61M
YoY Change	53.0%	8.78%	2.17%
% of Gross Profit
Depreciation & Amortization	$200.0K	$204.0K	$186.0K
YoY Change	-39.76%	9.68%	-33.09%
% of Gross Profit
Operating Expenses	$59.16M	$39.03M	$24.61M
YoY Change	99.59%	58.61%	2.17%
Operating Profit	-$59.16M	-$39.03M	-$35.71M
YoY Change	44.64%	9.3%	1.9%
Interest Expense	$9.215M	$8.231M	$7.933M
YoY Change	16.17%	3.76%	60.55%
% of Operating Profit
Other Income/Expense, Net	$3.247M	$3.415M	$3.963M
YoY Change	-28.43%	-13.83%	703.85%
Pretax Income	-$65.13M	-$43.85M	-$39.68M
YoY Change	47.03%	10.5%	0.48%
Income Tax
% Of Pretax Income
Net Earnings	-$56.04M	-$37.18M	-$33.70M
YoY Change	50.24%	10.34%	2.09%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.97	-$0.63	-$0.54
Diluted Earnings Per Share	-$0.96	-$0.63	-$0.54
COMMON SHARES
Basic Shares Outstanding	57.94M	57.94M	62.83M
Diluted Shares Outstanding			62.83M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$158.9M	$230.3M	$371.5M
YoY Change	-53.43%	-38.01%	161.21%
Cash & Equivalents	$2.120M	$1.831M	$3.800M
Short-Term Investments	$156.8M	$228.5M	$367.7M
Other Short-Term Assets	$6.273M	$13.46M	$6.708M
YoY Change	-10.4%	100.7%	-12.0%
Inventory
Prepaid Expenses
Receivables	$36.47M	$36.51M	$38.67M
Other Receivables	$1.274M	$656.0K	$302.0K
Total Short-Term Assets	$202.9M	$281.0M	$417.0M
YoY Change	-47.77%	-32.63%	98.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.034M	$1.804M	$22.36M
YoY Change	-90.76%	-91.93%	-8.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.054M	$1.054M	$1.054M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$153.4M	$156.5M	$143.1M
YoY Change	10.46%	9.39%	-10.03%
TOTAL ASSETS
Total Short-Term Assets	$202.9M	$281.0M	$417.0M
Total Long-Term Assets	$153.4M	$156.5M	$143.1M
Total Assets	$356.3M	$437.5M	$560.1M
YoY Change	-32.44%	-21.89%	51.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.502M	$6.182M	$6.446M
YoY Change	-31.93%	-4.1%	-12.24%
Accrued Expenses	$27.97M	$28.40M	$30.82M
YoY Change	-6.13%	-7.85%	29.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$19.43M	$19.13M	$97.50M
YoY Change	-80.47%	-80.38%
Total Short-Term Liabilities	$59.48M	$59.06M	$139.2M
YoY Change	-58.56%	-57.57%	296.94%
LONG-TERM LIABILITIES
Long-Term Debt	$403.7M	$430.9M	$344.3M
YoY Change	17.89%	25.17%	9.67%
Other Long-Term Liabilities	$17.72M	$18.84M	$21.74M
YoY Change	-15.29%	-13.33%	-13.8%
Total Long-Term Liabilities	$421.4M	$449.8M	$366.0M
YoY Change	15.98%	22.88%	7.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.48M	$59.06M	$139.2M
Total Long-Term Liabilities	$421.4M	$449.8M	$366.0M
Total Liabilities	$480.9M	$508.8M	$505.2M
YoY Change	-5.13%	0.72%	35.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$846.8M	-$790.7M	-$669.4M
YoY Change	19.82%	18.12%	-6.52%
Common Stock	$722.2M	$719.4M	$724.4M
YoY Change	-0.7%	-0.69%	1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$124.6M	-$71.33M	$54.94M
YoY Change
Total Liabilities & Shareholders Equity	$356.3M	$437.5M	$560.1M
YoY Change	-32.44%	-21.89%	51.69%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$56.04M	-$37.18M	-$33.70M
YoY Change	50.24%	10.34%	2.09%
Depreciation, Depletion And Amortization	$200.0K	$204.0K	$186.0K
YoY Change	-39.76%	9.68%	-33.09%
Cash From Operating Activities	-$45.99M	-$41.80M	$174.5M
YoY Change	42.19%	-123.95%	-1248.56%
INVESTING ACTIVITIES
Capital Expenditures	$80.00K	$58.00K	$0.00
YoY Change	-70.91%
Acquisitions
YoY Change
Other Investing Activities	$73.23M	-$61.87M	-$181.3M
YoY Change	105.41%	-65.88%	136.07%
Cash From Investing Activities	$73.15M	-$61.93M	-$181.3M
YoY Change	106.78%	-65.85%	136.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.88M	$98.43M	-388.0K
YoY Change	10236.92%	-25468.81%	-340.99%
NET CHANGE
Cash From Operating Activities	-45.99M	-$41.80M	174.5M
Cash From Investing Activities	73.15M	-$61.93M	-181.3M
Cash From Financing Activities	-26.88M	$98.43M	-388.0K
Net Change In Cash	289.0K	-$5.274M	-7.180M
YoY Change	-89.58%	-26.55%	-92.18%
FREE CASH FLOW
Cash From Operating Activities	-$45.99M	-$41.80M	$174.5M
Capital Expenditures	$80.00K	$58.00K	$0.00
Free Cash Flow	-$46.07M	-$41.86M	$174.5M
YoY Change	41.23%	-123.99%	-1248.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57944159
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1831000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7105000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	228503000	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001285819
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	OMEROS CORP
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57942695
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57942695
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61128597
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61128597
CY2023Q1	us-gaap	Depreciation Depreciation	200000	usd
CY2024Q1	omer	Number Of Options To Extend Lease Term NumberOfOptionsToExtendLeaseTerm	2	pure
CY2024Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-34475
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WA
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1663741
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 Elliott Avenue West
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98119
CY2024Q1	dei	City Area Code CityAreaCode	206
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	676-5000
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	OMER
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	164743000	usd
CY2024Q1	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29519000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	7642000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13463000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8581000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	280958000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	217898000	usd
CY2024Q1	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	135909000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17767000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18631000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1804000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2024Q1	us-gaap	Assets Assets	437492000	usd
CY2023Q4	us-gaap	Assets Assets	378269000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6182000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7712000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28402000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31868000	usd
CY2024Q1	omer	Royalty Obligation Current RoyaltyObligationCurrent	19130000	usd
CY2023Q4	omer	Royalty Obligation Current RoyaltyObligationCurrent	8576000	usd
CY2024Q1	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5342000	usd
CY2023Q4	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5160000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	59056000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53316000	usd
CY2024Q1	us-gaap	Senior Long Term Notes SeniorLongTermNotes	213463000	usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	213155000	usd
CY2024Q1	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	217459000	usd
CY2023Q4	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	116550000	usd
CY2024Q1	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	16754000	usd
CY2023Q4	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	18143000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2088000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2088000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	579000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	611000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	718807000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727936000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-790714000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-753530000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-71328000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	437492000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	378269000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26770000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24610000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12264000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11103000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	39034000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	35713000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-39034000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-35713000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	8231000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7933000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	3415000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	3963000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-43850000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39683000	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	6666000	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5982000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-37184000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-33701000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.75
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.63
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.12
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.09
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58800716
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62828765
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	32000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11851000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2658000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-37184000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-71328000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	85684000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2953000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-33701000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	54936000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-37184000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-33701000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2658000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2953000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1387000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	477000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	204000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	186000	usd
CY2024Q1	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-4343000	usd
CY2023Q1	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-3925000	usd
CY2024Q1	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	2339000	usd
CY2023Q1	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	1677000	usd
CY2024Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	1893000	usd
CY2023Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	2316000	usd
CY2024Q1	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-9363000	usd
CY2023Q1	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-9203000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-454000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-203188000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5090000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	582000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4997000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	733000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41780000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	174539000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	487554000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	523941000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	425687000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	342610000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61925000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-181331000	usd
CY2024Q1	omer	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	115525000	usd
CY2023Q1	omer	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	164762000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11851000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2024Q1	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	5141000	usd
CY2023Q1	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	278000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	134000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	110000	usd
CY2024Q1	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	32000	usd
CY2023Q1	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	98431000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-388000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5274000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7180000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7105000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11009000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1831000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3829000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	7152000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7933000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	230300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41800000	usd
CY2024Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2022Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.30	pure
CY2023Q1	omer	Percentage Of Interest Earned On Outstanding Contract Royalty Asset PercentageOfInterestEarnedOnOutstandingContractRoyaltyAsset	0.11	pure
CY2024Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	229537000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	164743000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: left; text-indent: 9pt;"><i>Financial Instruments and Concentrations of Credit Risk</i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;text-indent:18pt;"> </p> <div style="font-size: 10pt; text-indent: 18pt;"> F <span style="font-size:10pt;">inancial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Cash and cash equivalents are deposited in checking and sweep accounts at financial institutions. At times, our cash and cash equivalents balance held at a financial institution <em style="font: inherit;"> may </em>exceed the federally insured limits. To limit the credit risk, we invest our excess cash in high-quality securities such as money market mutual funds, certificates of deposit and U.S. treasury bills. The Company has <em style="font: inherit;">not</em> experienced any losses on its deposits of cash and cash equivalents. Management believes that the Company is <em style="font: inherit;">not</em> currently exposed to significant credit risk as the Company’s short-term investments are held in custody at <em style="font: inherit;">third</em>-party financial institutions. The Company’s investment policy limits investments to certain types of securities issued by the U.S. government, its agencies and institutions with investment-grade credit ratings and places restrictions on maturities and concentration by type and issuer. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash, cash equivalents and investments, and issuers of the investments to the extent recorded on the unaudited condensed consolidated balance sheets. As of <em style="font: inherit;"> March 31, 2024, </em>the Company has <em style="font: inherit;">no</em> off-balance sheet concentrations of credit risk.</span></div>
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11776805
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17223451
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2800000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3400000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	228503000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-20000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	228483000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	229557000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-20000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	165797000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	165816000	usd
CY2024Q1	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29519000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2024Q1	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	135909000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2024Q1	omer	Contract Royalty Asset ContractRoyaltyAsset	165428000	usd
CY2023Q4	omer	Contract Royalty Asset ContractRoyaltyAsset	168109000	usd
CY2024Q1	omer	Royalty Receivable RoyaltyReceivable	6986000	usd
CY2023Q4	omer	Royalty Receivable RoyaltyReceivable	6724000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	656000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1372000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	7642000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12249000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12191000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10445000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10241000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1804000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	200000	usd
CY2024Q1	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	9357000	usd
CY2023Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	10168000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8799000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7380000	usd
CY2024Q1	omer	Accrued Contract Research Costs AccruedContractResearchCosts	5344000	usd
CY2023Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	6223000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2308000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3539000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1417000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4242000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1177000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	316000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	28402000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31868000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3142000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3258000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due Next Twelve Months RoyaltyObligationPrincipalPaymentsDueNextTwelveMonths	14147000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due Next Twelve Months RoyaltyObligationInterestPaymentsDueNextTwelveMonths	16764000	usd
CY2024Q1	omer	Royalty Obligation Payments Due Next Twelve Months RoyaltyObligationPaymentsDueNextTwelveMonths	30911000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due Year Two RoyaltyObligationPrincipalPaymentsDueYearTwo	20990000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due Year Two RoyaltyObligationInterestPaymentsDueYearTwo	20672000	usd
CY2024Q1	omer	Royalty Obligation Payments Due Year Two RoyaltyObligationPaymentsDueYearTwo	41662000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due Year Three RoyaltyObligationPrincipalPaymentsDueYearThree	23991000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due Year Three RoyaltyObligationInterestPaymentsDueYearThree	18504000	usd
CY2024Q1	omer	Royalty Obligation Payments Due Year Three RoyaltyObligationPaymentsDueYearThree	42495000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due Year Four RoyaltyObligationPrincipalPaymentsDueYearFour	27314000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due Year Four RoyaltyObligationInterestPaymentsDueYearFour	16032000	usd
CY2024Q1	omer	Royalty Obligation Payments Due Year Four RoyaltyObligationPaymentsDueYearFour	43346000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due Year Five RoyaltyObligationPrincipalPaymentsDueYearFive	30991000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due Year Five RoyaltyObligationInterestPaymentsDueYearFive	13221000	usd
CY2024Q1	omer	Royalty Obligation Payments Due Year Five RoyaltyObligationPaymentsDueYearFive	44212000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due After Year Five RoyaltyObligationPrincipalPaymentsDueAfterYearFive	119156000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due After Year Five RoyaltyObligationInterestPaymentsDueAfterYearFive	18857000	usd
CY2024Q1	omer	Royalty Obligation Payments Due After Year Five RoyaltyObligationPaymentsDueAfterYearFive	138013000	usd
CY2024Q1	omer	Royalty Obligation Principal Payments Due RoyaltyObligationPrincipalPaymentsDue	236589000	usd
CY2024Q1	omer	Royalty Obligation Interest Payments Due RoyaltyObligationInterestPaymentsDue	104050000	usd
CY2024Q1	omer	Royalty Obligation Payments Due RoyaltyObligationPaymentsDue	340639000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1100000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1606000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1633000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	145000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	118000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	56000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	51000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	916000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	790000	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	388000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	375000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	2335000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2217000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1815000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1780000	usd
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	179000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	152000	usd
CY2024Q1	omer	Longterm Purchase Commitment Termination Fee LongtermPurchaseCommitmentTerminationFee	23300000	usd
CY2021Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2023Q4	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3200000
CY2024Q1	omer	Stock Repurchased And Retired Average Price Per Share StockRepurchasedAndRetiredAveragePricePerShare	3.71
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11900000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5000000
	omer	Stock Repurchased And Retired Average Price Per Share StockRepurchasedAndRetiredAveragePricePerShare	3.3
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2658000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2953000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15255154
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.5
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	29800
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.5
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9339
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.46
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	124317
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.91
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15151298
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.5
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1894000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	14712513
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.65
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1746000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10966833
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.33
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	394000	usd
CY2024Q1	us-gaap	Share Price SharePrice	3.45

Files In Submission

Name	View Source	Status
0001437749-24-017047-index-headers.html	Edgar Link	pending
0001437749-24-017047-index.html	Edgar Link	pending
0001437749-24-017047.txt	Edgar Link	pending
0001437749-24-017047-xbrl.zip	Edgar Link	pending
ex_618340.htm	Edgar Link	pending
ex_618341.htm	Edgar Link	pending
ex_618342.htm	Edgar Link	pending
ex_618343.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
omer-20240331.xsd	Edgar Link	pending
omer20240331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
omer-20240331_lab.xml	Edgar Link	unprocessable
omer-20240331_def.xml	Edgar Link	unprocessable
omer-20240331_pre.xml	Edgar Link	unprocessable
omer20240331_10q_htm.xml	Edgar Link	completed
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
omer-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMER
OMEROS CORP Stock $omer

2024 Q2 Form 10-Q Financial Statement

#000143774924017047 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER OMEROS CORP Stock $omer

2024 Q2 Form 10-Q Financial Statement

#000143774924017047 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER
OMEROS CORP Stock $omer